We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A 3D model of a human brain.

Hidden Brain Region May Unlock New Epilepsy Treatment

Cell therapy.

Cell Therapy Treatment Effectively Treats Immune-Compromised Children

A selection of diabetes monitoring and treatment neccessities.

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

Cannabinols Show Neuroprotective Properties in Fruit Flies

News

Adaptimmune Secures $104 Million in Series A Financing

Company will use funding to advance programmes in multiple cancer indications.

NIH Funds Next Phase of Tissue Chip for Drug Screening Program

Scientists will integrate chips mimicking human organ functions into full body system to evaluate drugs.

New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors

Detailing how to achieve consistent feeding regimes for reproducible scale-up.

Tekmira Joins Ebola International Consortium

Tekmira joins international consortium to conduct clinical trials of Ebola virus therapeutics in West Africa.

Covance and Frenova Renal Collaboration

Researchers will share and analyze data to improve lives of patients living with chronic kidney disease and end stage renal disease.

Quotient Clinical Showcases ‘Gold Standard’ Human ADME Studies and Applications

Company will present a symposium and three poster publications at ISSX/JSSX 2014.

Adaptimmune Named as One of “Fierce 15” Biotech Companies of 2014

Company has created T-cell receptors which are deployed to target NY-ESO-1.

Horizon Reports a Strong First Half

Interim results for the six months ended 30 June 2014 position the company for continued growth.

Jumpstart Joins Bionow

Membership will aim to help life science businesses in Northern England.

Positive Results from an Exploratory Phase I/II Study with UC1010 in PMDD

Results show a significant improvement of symptoms in patients treated with UC1010.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter